Keyphrases
Obesity
100%
Weight Loss
57%
Gastric Emptying
36%
Satiation
29%
Anti-obesity
22%
Irritable Bowel Syndrome
20%
Intragastric Balloon
18%
Roux-en-Y Gastric Bypass
18%
Bariatric Surgery
17%
Satiety
16%
Obesity Management
16%
Patients with Obesity
15%
Gastrointestinal
15%
Body Mass Index
15%
Weight Loss Outcomes
15%
Glucagon-like
13%
Functional Constipation
13%
Colonic Transit
13%
Endoscopic Sleeve Gastroplasty
13%
Leptin-melanocortin Pathway
13%
Liraglutide
13%
Metabolic Surgery
12%
Obesity Treatment
12%
Food Intake
12%
Semaglutide
12%
Placebo
10%
Weight Gain
10%
Type 2 Diabetes Mellitus (T2DM)
10%
Total Body Weight
9%
Fecal Bile Acids
9%
Food Intake Regulation
9%
Meta-analysis
9%
Precision Medicine
9%
Diarrhea
9%
Non-carriers
9%
Relamorelin
8%
Gastrointestinal Diseases
8%
Sleeve Gastrectomy
8%
Overweight or Obesity
8%
Gastric Volume
8%
Balloon
8%
Heterozygous Variant
7%
Bile Acids
7%
Fluid-filled
7%
Systematic Meta-analysis
7%
Endoscopic Bariatric Therapy
7%
Type 2 Diabetes Mellitus Remission
7%
Gastric Sleeve
7%
Bowel Function
7%
Constipation
7%
Medicine and Dentistry
Satiety
40%
Stomach Emptying
34%
Body Mass Index
25%
Body Weight
23%
Diseases
21%
Bariatric Surgery
21%
Obesity Medicine
17%
Food Intake
16%
Patient with Obesity
16%
Maturity Onset Diabetes of the Young
15%
Caloric Intake
15%
Roux-en-Y Gastric Bypass
14%
Placebo
14%
Irritable Bowel Syndrome
13%
Gastroplasty
13%
Diarrhea
12%
Diabetes
11%
Semaglutide
11%
Nonalcoholic Fatty Liver
11%
Obesity Management
11%
Liraglutide
10%
Gut
10%
Systematic Review
10%
Bile Acid
10%
Body Weight Loss
10%
Anti-Obesity Medication
10%
Personalized Medicine
10%
Cardiovascular Disease
9%
Glucagon Like Peptide 1
9%
Prevalence
9%
Meta-Analysis
9%
Lifestyle Intervention
9%
Weight Management
9%
Melanocortin
8%
Leptin
8%
Constipation
8%
Motor Performance
8%
Sleeve Gastrectomy
8%
Drug Therapy
7%
Malignant Neoplasm
7%
Endoscopy
7%
Chronic Constipation
7%
Comorbidity
7%
Enteroendocrine Cell
6%
Relamorelin
6%
Odds Ratio
6%
Prospective Study
6%
Melanocortin 4 Receptor
6%
Pathophysiology
5%
Adverse Event
5%